Europe Veterinary Diagnostics Products Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Europe Veterinary Diagnostics Products Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Kits and Reagents and Analyzers), Kits And Reagents - Product (ELISA Test Kits, Antibodies Test Kits, Polymerase Chain Reaction (PCR) Test Kits, Hematology Test Kits, Biochemistry Test Kits, Immunoassay Reagents, and Others), Analyzers - Product (Biochemistry Analyzers, Hematology Analyzers, Immunoassay Analyzers, PCR Analyzers, and Others), Animal Type (Companion Animal and Livestock Animal), Companion Animal - Animal Type (Dogs, Cats, Horses, and Others), Livestock Animal - Animal Type (Cattles, Pigs, Poultry, and Others), Application (Infectious Diseases and Non-Infectious Diseases), Infectious Diseases - Application (Rabies, Avian Influenza, Leishmania, Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection, and Others), Non-infectious Diseases - Application (Pneumonia, Gastritis, Bronchitis, and Others), and End User (Public Healthcare Facilities and Private Healthcare Facilities)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Status : Published
  • Report Code : TIPRE00042921
  • Category : Life Sciences
  • No. of Pages : 306
  • Available Report Formats : pdf-format excel-format
Buy Now
Europe Veterinary Diagnostics Products Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Feb 2026   |   Report Code: TIPRE00042921 Email: sales@theinsightpartners.com
Buy Now

The Europe Veterinary Diagnostics Products Market size is expected to reach US$ 4,514.2 Million by 2031 from US$ 2,373.9 Million in 2024. The market is estimated to record a CAGR of 9.7% from 2025 to 2031.

Executive Summary and Europe Veterinary Diagnostics Products Market Analysis:

The veterinary diagnostics products market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The European market is growing significantly due to prominent players, technological advancements, and the awareness among pet owners about the importance of preventive healthcare. Europe has stringent animal health regulations, and it emphasizes animal welfare, which encourages using accurate diagnostic tools to ensure proper disease management and control. Germany, France, and the UK, among others, have well-established veterinary infrastructures and government initiatives supporting animal health, stimulating market expansion.

Countries with high livestock densities and exports, such as Germany, France, the UK, and Spain, are seeing especially vibrant market activity, spurred by stricter traceability, the European Animal Health Law, and escalating investments in biosecurity and zoonotic disease response. Diagnostic innovation in Europe is catalyzed by integrating point-of-care (PoC) platforms, molecular and immunodiagnostic technologies, and AI-powered digital health solutions, facilitating real-time surveillance, herd health management, and early detection of diseases. PoC consumables, reagents, and diagnostic kits are the highest revenue-generating segment, comprising over half the product market and experiencing the fastest unit growth due to widespread adoption among veterinary hospitals, mobile services, and in-house clinics. Recent regulatory developments, particularly the harmonization of animal health laws and new protocols for notifiable and emerging diseases, have strengthened the market's ability to respond to challenges such as antimicrobial resistance, avian influenza, and African swine fever. Numerous EU-driven programs now fund continuous research and the deployment of laboratory infrastructure, supporting initiatives for improved test accuracy and throughput. This enables veterinarians and livestock producers to identify infectious threats immediately and contain outbreaks before they escalate, thus protecting the agricultural economy and public health. European innovators and manufacturers such as Virbac, Zoetis, and Esaote have expanded their reach within the region, partnering with local and national authorities to roll out new diagnostics platforms and AI-backed imaging solutions customized for both large-scale farm settings and small animal clinics. Telemedicine and remote diagnostics have gained momentum, providing new access in rural or underserved communities and boosting adoption rates for in-clinic devices, digital pathology, and rapid screening kits among practitioners.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Europe Veterinary Diagnostics Products Market: Strategic Insights

europe-veterinary-diagnostics-products-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Veterinary Diagnostics Products Market Segmentation Analysis:

  • By Product, the Europe Veterinary Diagnostics Products Market is segmented into Kits and Reagents and Analyzers. The Kits and Reagents segment dominated the market in 2024.
  • By Kits And Reagents - Product, the Europe Veterinary Diagnostics Products Market is segmented into ELISA Test Kits, Antibodies Test Kits, Polymerase Chain Reaction (PCR) Test Kits, Hematology Test Kits, Biochemistry Test Kits, Immunoassay Reagents, and Others. The ELISA Test Kits segment dominated the market in 2024.
  • By Analyzers - Product, the Europe Veterinary Diagnostics Products Market is segmented into Biochemistry Analyzers, Hematology Analyzers, Immunoassay Analyzers, PCR Analyzers, and Others. The Hematology Analyzers segment dominated the market in 2024.
  • By Animal Type, the Europe Veterinary Diagnostics Products Market is segmented into Companion Animal and Livestock Animal. The Companion Animal segment dominated the market in 2024.
  • By Companion Animal - Animal Type, the Europe Veterinary Diagnostics Products Market is segmented into Dogs, Cats, Horses, and Others. The Dogs segment dominated the market in 2024.
  • By Livestock Animal - Animal Type, the Europe Veterinary Diagnostics Products Market is segmented into Cattles, Pigs, Poultry, and Others. The Cattles segment dominated the market in 2024.
  • By Application, the Europe Veterinary Diagnostics Products Market is segmented into Infectious Diseases and Non-Infectious Diseases. The Infectious Diseases segment dominated the market in 2024.
  • By Infectious Diseases - Application, the Europe Veterinary Diagnostics Products Market is segmented into Rabies, Avian Influenza, Leishmania, Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection, and Others. The Rabies segment dominated the market in 2024.
  • By Non-infectious Diseases - Application, the Europe Veterinary Diagnostics Products Market is segmented into Pneumonia, Gastritis, Bronchitis, and Others. The Pneumonia segment dominated the market in 2024.
  • By End User, the Europe Veterinary Diagnostics Products Market is segmented into Public Healthcare Facilities and Private Healthcare Facilities. The Public Healthcare Facilities segment dominated the market in 2024.

Europe Veterinary Diagnostics Products Market Report Scope

Report Attribute Details
Market size in 2024 US$ 2,373.9 Million
Market Size by 2031 US$ 4,514.2 Million
CAGR (2025 - 2031) 9.7%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Kits and Reagents
  • Analyzers
By Kits And Reagents - Product
  • ELISA Test Kits
  • Antibodies Test Kits
  • Polymerase Chain Reaction [PCR] Test Kits
  • Hematology Test Kits
  • Biochemistry Test Kits
  • Immunoassay Reagents
  • Others
By Analyzers - Product
  • Biochemistry Analyzers
  • Hematology Analyzers
  • Immunoassay Analyzers
  • PCR Analyzers
  • Others
By Animal Type
  • Companion Animal
  • Livestock Animal
Regions and Countries Covered Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Randox Laboratories Ltd
  • Zoetis Inc
  • Fujifilm Corp
  • Bionote Inc
  • Ubio Biotechnology Systems Pvt Ltd
  • VMRD Inc
  • Gold Standard Diagnostics Budapest Kft
  • Secure Diagnostics Pvt Ltd
  • InBios International Inc

Europe Veterinary Diagnostics Products Market Players Density: Understanding Its Impact on Business Dynamics

The Europe Veterinary Diagnostics Products Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

europe-veterinary-diagnostics-products-market-cagr

Europe Veterinary Diagnostics Products Market Outlook

According to a report by HealthforAnimals published in 2024, the global pet population exceeded to 1 billion animals, with over 470 million dogs and 370 million cats worldwide as of 2018, and continued growth observed through 2024. This surge is driven by urbanization, evolving lifestyles, and heightened emotional bonds with companion animals, especially dogs and cats, as highlighted in global sector analyses. Urban dwellers, now comprising over half the world's population, increasingly seek pets for companionship in fast-paced city environments, leading to preferences for smaller breeds suited to compact living spaces. This growing pet population fuels demand for diagnostic kits for diseases such as canine parvovirus and feline leukemia, as owners prioritize preventive healthcare.

The State of Pet Homelessness Index by Mars Petcare (2024) estimates that 1 in 3 companion animals globally-over 600 million dogs and cats-are homeless or at risk, underscoring the urgent need for adoption programs.

Companion animal adoption trends are steadily increasing, driven by a growing awareness of animal welfare and efforts to reduce stray populations. The State of Pet Homelessness Index by Mars Petcare (2024) estimates that 1 in 3 companion animals globally-over 600 million dogs and cats-are homeless or at risk, underscoring the urgent need for adoption programs. This has spurred global efforts, including education campaigns and partnerships, resulting in improved household adoption rates and shifting perceptions toward shelter animals.

The escalation in pet ownership and companion animal adoption fuels demand for veterinary diagnostic kits in India by increasing the need for timely disease detection, health monitoring, and preventive care for pets.

Europe Veterinary Diagnostics Products Market Country Insights

By country, the Europe Veterinary Diagnostics Products Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2024.

Germany has a well-developed animal diagnostics sector, with private and public laboratories providing various services. The market is experiencing growth, focusing on rapid on-site diagnostics and advanced technologies such as molecular biology and genomics. For instance, the Institute for Animal Health of LUFA Nord-West, situated in Oldenburg (Germany), has a wide variety of services on offer covering animal health to farmers, vets, breeding associations, and trade firms. It's an accredited diagnostic laboratory that warrants consistently reliable results through its quality assurance system.

The presence of prominent market players favors the progress of the veterinary diagnostics products market in Germany. In April 2024, Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, launched the advanced in-hospital Nu. Q Canine Cancer Test in Germany. Moreover, in November 2022, INDICAL launched an updated and even more efficient range of Virotype 2.0 PCR kits. The latest Virotype 2.0 family cycling protocol and reaction setup kits from INDICAL are validated, updated, and streamlined for optimal performance. They feature new product designs and, most significantly, share one family cycling protocol across all assays. The veterinary diagnostics products market in Germany is experiencing robust growth, driven by technological advancements, increased demand for animal healthcare, and a focus on improving livestock productivity and companion animal health. Technological innovations are pivotal in shaping the market landscape. Companies such as IDEXX Laboratories have introduced advanced diagnostic platforms, such as the TRUFORMA system, which utilizes bulk acoustic wave technology for real-time diagnostics. This platform addresses a substantial market opportunity and has expanded its reach beyond the U.S. following CE mark certification in 2024, enabling entry into the European market. Additionally, advancements in machine learning algorithms have facilitated early disease detection in veterinary care, enhancing the identification of subclinical abnormalities during wellness visits. The German government has also actively promoted animal health and veterinary diagnostics. Initiatives such as the National Animal Health Program aim to enhance disease surveillance, improve diagnostic capabilities, and strengthen the veterinary infrastructure. The veterinary diagnostics products market in Germany is poised for continued expansion, driven by technological advancements, increased demand for diagnostic services, and supportive government initiatives. The integration of AI and molecular diagnostics is expected to drive innovations in the country. In contrast, expanding diagnostic platforms into international markets will broaden the reach and impact of veterinary diagnostics.

Europe Veterinary Diagnostics Products Market Company Profiles

Some of the key players operating in the market include Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Zoetis Inc, Fujifilm Corp, Bionote Inc, Ubio Biotechnology Systems Pvt Ltd, VMRD Inc, Gold Standard Diagnostics Budapest Kft, Secure Diagnostics Pvt Ltd, and InBios International Inc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Veterinary Diagnostics Products Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: May 2026